131 related articles for article (PubMed ID: 31152438)
1. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
[TBL] [Abstract][Full Text] [Related]
2. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
Hu H; Zhang L; Teng G; Wu Y; Chen Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
[TBL] [Abstract][Full Text] [Related]
3. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
4. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
[TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism in the 3'-untranslated region of the KRAS gene disrupts the interaction with let-7a and enhances the metastatic potential of osteosarcoma cells.
Zhang S; Hou C; Li G; Zhong Y; Zhang J; Guo X; Li B; Bi Z; Shao M
Int J Mol Med; 2016 Sep; 38(3):919-26. PubMed ID: 27430246
[TBL] [Abstract][Full Text] [Related]
6. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
[TBL] [Abstract][Full Text] [Related]
7. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.
Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB
Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697
[TBL] [Abstract][Full Text] [Related]
9. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
[TBL] [Abstract][Full Text] [Related]
10. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.
Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M
Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923
[TBL] [Abstract][Full Text] [Related]
11. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
Wu K; Yang Y; Zhao J; Zhao S
Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS.
Han J; Wang L; Wang X; Li K
Med Sci Monit; 2016 Feb; 22():522-9. PubMed ID: 26883054
[TBL] [Abstract][Full Text] [Related]
13. Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.
Crowley EH; Arena S; Lamba S; Di Nicolantonio F; Bardelli A
Hum Mutat; 2014 Feb; 35(2):208-14. PubMed ID: 24282149
[TBL] [Abstract][Full Text] [Related]
14. Let-7g induces granulosa cell apoptosis by targeting MAP3K1 in the porcine ovary.
Cao R; Wu W; Zhou X; Liu K; Li B; Huang X; Zhang Y; Liu H
Int J Biochem Cell Biol; 2015 Nov; 68():148-57. PubMed ID: 26299328
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
16. The MicroRNA hsa-let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1.
Cui F; Zhou Q; Xiao K; Ma S
Yonsei Med J; 2020 Mar; 61(3):210-217. PubMed ID: 32102121
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma.
Zhao Z; Wen J; Peng L; Liu H
Med Sci Monit; 2019 Aug; 25():5747-5756. PubMed ID: 31374070
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
[TBL] [Abstract][Full Text] [Related]
19. An let-7 KRAS rs712 polymorphism increases hepatocellular carcinoma risk.
Xiong D; Song YP; Xiong W; Liang YD
Genet Mol Res; 2015 Oct; 14(4):14050-5. PubMed ID: 26535719
[TBL] [Abstract][Full Text] [Related]
20. MiR-16 inhibits proliferation of cervical cancer cells by regulating KRAS.
Ding Z; Liu SJ; Liu XW; Ma Q; Qiao Z
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10419-10425. PubMed ID: 33155198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
